New Delhi, India

Nitin Saigal

This inventor holds 1 USPTO granted patent. Top assignee: Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nitin Saigal. Retrieved from https://idiyas.com/inventor/nitin-saigal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nitin Saigal: Innovator in Vaccine Development

Introduction

Nitin Saigal is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of vaccine development, particularly focusing on improving the stability and accessibility of vaccines for developing countries. His work aims to enhance public health through innovative solutions.

Latest Patents

Nitin Saigal holds a patent for a "Thermostable spray dried rotavirus vaccine formulation and process thereof." This invention relates to an improved formulation of a rotavirus vaccine that is thermostable, making it easier to transport and use in various conditions. The vaccine is designed to be affordable and has a better chance of being adopted in vaccination programs in low-income countries.

Career Highlights

Nitin Saigal is currently associated with MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. His work at this organization focuses on developing vaccines that can withstand challenging environmental conditions, thereby improving immunization rates in underserved populations.

Collaborations

Some of his notable coworkers include Davinder Gill and Sachin Kale. Together, they contribute to the advancement of vaccine technology and public health initiatives.

Conclusion

Nitin Saigal's innovative work in vaccine formulation exemplifies the importance of research and development in addressing global health challenges. His contributions are vital for improving vaccine accessibility and effectiveness in developing regions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…